Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Terns Pharmaceuticals (TERN) Other Gross PP&E Adjustments (2020 - 2023)

Terns Pharmaceuticals' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$2.6 million for Q3 2023.

  • For Q3 2023, Other Gross PP&E Adjustments fell 28.7% year-over-year to -$2.6 million; the TTM value through Dec 2023 reached -$2.6 million, down 7.18%, while the annual FY2022 figure was -$2.4 million, 475.5% down from the prior year.
  • Other Gross PP&E Adjustments reached -$2.6 million in Q3 2023 per TERN's latest filing, up from -$3.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $649000.0 in Q4 2021 to a low of -$3.0 million in Q2 2023.
  • Average Other Gross PP&E Adjustments over 4 years is -$1.6 million, with a median of -$2.2 million recorded in 2022.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 302.18% in 2021, then tumbled 475.5% in 2022.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$321000.0 in 2020, then skyrocketed by 302.18% to $649000.0 in 2021, then crashed by 475.5% to -$2.4 million in 2022, then decreased by 8.58% to -$2.6 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Other Gross PP&E Adjustments are -$2.6 million (Q3 2023), -$3.0 million (Q2 2023), and -$2.5 million (Q1 2023).